Keyur Vora, MD, MS, George Revtyak, MD, and Rohan Dharmakumar, PhD with the first patient to enroll in a new cardiovascular clinical trial.
News | Cardiovascular Clinical Studies
First Patient Enrolls in IU-led Clinical Trial to Study Treatment for Acute Heart Attack Complications

December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients ...

Home December 27, 2022
Home
Photo by: Congressman Andy Barr
News | Cardiovascular Business
CAROL Act to Expand Research Funding, Raise Awareness for Valvular Heart Disease

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy ...

Home December 27, 2022
Home
Two-day educational symposium was held in New York City at the NBPA’s headquarters 
News | Cardiovascular Education
Morristown Medical Center’s Matthew Martinez, MD Held First Sports Cardiology Summit for Elite and Professional Athletes

December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows ...

Home December 26, 2022
Home
Limited Exclusion Order would bar Apple from importing infringing Apple Watches 
News | ECG
ITC Rules Apple Violated AliveCor’s Patents

December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...

Home December 26, 2022
Home
Happy Holidays from DAIC
News | Diagnostic and Interventional Cardiology DAIC
Happy Holidays from DAIC

December 25, 2022 — The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and ...

Home December 25, 2022
Home
According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be valued at $2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).
News | Stents Drug Eluting
Global Drug Eluting Stents Market to Surpass US$ 4,844.6 Million by 2030, Says Coherent Market Insights

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

Home December 23, 2022
Home
The first of its kind study involved 60 patients and confirmed Electroducer Sleeve as a safe and effective treatment for heart diseases
News | Guidewires
Electroducer announces the publication of positive results from its pilot study in EuroIntervention medical journal

December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment ...

Home December 23, 2022
Home
Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.
News | Cardiovascular Business
Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...

Home December 22, 2022
Home
Individuals with coronary artery disease exist on a spectrum of disease, such as the amount of plaque build-up in the arteries of the heart; however, the disease is conventionally classified as broad categories of case (yes disease) or control (no disease), which may result in misdiagnosis. A digital marker for coronary artery disease derived from machine learning and electronic health records can better quantify where an individual falls on the disease spectrum. Credit: Icahn School of Medicine at Mount Si
News | Heart Failure
Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...

Home December 22, 2022
Home
The AcQCross Qx system combines the dilator and needle needed to perform left-atrial appendage closure procedures, eliminating the need to swap equipment mid-surgery while crossing into the left side of the heart. (Pixabay)
News | Left Atrial Appendage (LAA) Occluders
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

Home December 22, 2022
Home
Collaborative team from Rockefeller University, Cleveland Clinic publish findings in Science
News | Coronavirus (COVID-19)
Research Identifies Potential Genetic Cause for MIS-C Complication Following COVID-19 Infection

December 22, 2022 — New research findings have revealed an underlying genetic cause for why some children who have had ...

Home December 22, 2022
Home
The Arrhythmia Care Team at Corewell Health Celebrate First Successful Procedures With New Genesis Robotic Cardiac Ablation System from Stereotaxis.
News
Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint
News | Cardiovascular Clinical Studies
CLEAR Outcomes Accepted as Late-Breaking Clinical Trial at ACC.23 Annual Scientific Session & Expo together with the World Congress of Cardiology

December 21, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

Home December 21, 2022
Home
Robbin Cohen, MD, now serves as director of the Cardiac Surgery Program at Huntington Health, a Cedars-Sinai affiliate, and will be practicing out of Huntington Health’s Pasadena campus.
News | Cardiovascular Surgery
Cedars-Sinai Expands Cardiac Surgery at Huntington Health

December 21, 2022 — The Smidt Heart Institute at Cedars-Sinai is again expanding its geographic reach and surgical ...

Home December 21, 2022
Home
Arrow International, LLC, a Subsidiary of Teleflex, Inc, recalls Arrow AutoCAT 2, AC3 intra-aortic balloon pumps for unexpectedly short battery run times
Feature | Intra-Aortic Balloon Pumps (IABP)
Teleflex Recalls Arrow Intra-Aortic Balloon Pumps for Short Battery

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic ...

Home December 20, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now